Literature DB >> 22584727

Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis.

X Guo1, J Cui, M R Jones, T Haritunians, A H Xiang, Y-D I Chen, K D Taylor, T A Buchanan, R C Davis, W A Hsueh, L J Raffel, J I Rotter, M O Goodarzi.   

Abstract

AIMS/HYPOTHESIS: We have previously documented a high heritability of insulin clearance in a Hispanic cohort. Here, our goal was to confirm the high heritability in a second cohort and search for genetic loci contributing to insulin clearance.
METHODS: Hyperinsulinaemic-euglycaemic clamps were performed in 513 participants from 140 Hispanic families. Heritability was estimated for clamp-derived insulin clearance and a two-phase genome-wide linkage scan was conducted using a variance components approach. Linkage peaks were further investigated by candidate gene association analysis in two cohorts.
RESULTS: The covariate-adjusted heritability of insulin clearance was 73%, indicating that the majority of the phenotypic variance is due to genetic factors. In the Phase 1 linkage scan, no signals with a logarithm of odds (LOD) score >2 were detected. In the Phase 2 scan, two linkage peaks with an LOD >2 for insulin clearance were identified on chromosomes 15 (LOD 3.62) and 20 (LOD 2.43). These loci harbour several promising candidate genes for insulin clearance, with 12 single nucleotide polymorphisms (SNPs) on chromosome 15 and six SNPs on chromosome 20 being associated with insulin clearance in both Hispanic cohorts. CONCLUSIONS/
INTERPRETATION: In a second Hispanic cohort, we confirmed that insulin clearance is a highly heritable trait and identified chromosomal loci that harbour genes regulating insulin clearance. The identification of such genes may improve our understanding of how the body clears insulin, thus leading to improved risk assessment, diagnosis, prevention and therapy of diabetes, as well as of other hyperinsulinaemic disorders, such as the metabolic syndrome and polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584727      PMCID: PMC3391346          DOI: 10.1007/s00125-012-2577-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.

Authors:  S M Haffner; M P Stern; R M Watanabe; R N Bergman
Journal:  Eur J Clin Invest       Date:  1992-03       Impact factor: 4.686

2.  A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene.

Authors:  H Zouali; E H Hani; A Philippi; N Vionnet; J S Beckmann; F Demenais; P Froguel
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

3.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 4.  Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies.

Authors:  A J Scheen; N Paquot; M R Letiexhe; G Paolisso; M J Castillo; P J Lefèbvre
Journal:  Int J Obes Relat Metab Disord       Date:  1995-09

5.  Reduced hepatic insulin clearance in rats with dietary-induced obesity.

Authors:  G Strömblad; P Björntorp
Journal:  Metabolism       Date:  1986-04       Impact factor: 8.694

6.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; M A Charles; N Thibult; J L Richard; J R Claude; J M Warnet; G E Rosselin; E Eschwège
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

7.  Impaired in vivo insulin clearance in patients with severe target-cell resistance to insulin.

Authors:  J S Flier; K L Minaker; L Landsberg; J B Young; J Pallotta; J W Rowe
Journal:  Diabetes       Date:  1982-02       Impact factor: 9.461

8.  Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins: molecular cloning and characterization of a member of the ZHX family, ZHX3.

Authors:  Kazuya Yamada; Hiroko Kawata; Zhangfei Shou; Satoko Hirano; Tetsuya Mizutani; Takashi Yazawa; Toshio Sekiguchi; Miki Yoshino; Takashi Kajitani; Kaoru Miyamoto
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

9.  Oxidative stress activates both Src-kinases and their negative regulator Csk and induces phosphorylation of two targeting proteins for Csk: caveolin-1 and paxillin.

Authors:  Haiming Cao; Amy R Sanguinetti; Cynthia Corley Mastick
Journal:  Exp Cell Res       Date:  2004-03-10       Impact factor: 3.905

10.  STRP screening sets for the human genome at 5 cM density.

Authors:  Nader Ghebranious; David Vaske; Adong Yu; Chengfeng Zhao; Gabor Marth; James L Weber
Journal:  BMC Genomics       Date:  2003-02-24       Impact factor: 3.969

View more
  14 in total

1.  Hepatic but Not Extrahepatic Insulin Clearance Is Lower in African American Than in European American Women.

Authors:  Francesca Piccinini; David C Polidori; Barbara A Gower; Richard N Bergman
Journal:  Diabetes       Date:  2017-07-14       Impact factor: 9.461

2.  Reduced Insulin Clearance and Insulin-Degrading Enzyme Activity Contribute to Hyperinsulinemia in African Americans.

Authors:  Andin Fosam; Shanaz Sikder; Brent S Abel; Sri Harsha Tella; Mary F Walter; Andrea Mari; Ranganath Muniyappa
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

3.  The Association of Estrogen Receptor-β Gene Variation With Salt-Sensitive Blood Pressure.

Authors:  Worapaka Manosroi; Jia Wei Tan; Chevon M Rariy; Bei Sun; Mark O Goodarzi; Aditi R Saxena; Jonathan S Williams; Luminita H Pojoga; Jessica Lasky-Su; Jinrui Cui; Xiuqing Guo; Kent D Taylor; Yii-Der I Chen; Anny H Xiang; Willa A Hsueh; Leslie J Raffel; Thomas A Buchanan; Jerome I Rotter; Gordon H Williams; Ellen W Seely
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

4.  Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes.

Authors:  Richard N Bergman; Francesca Piccinini; Morvarid Kabir; Cathryn M Kolka; Marilyn Ader
Journal:  Diabetes       Date:  2019-09       Impact factor: 9.461

5.  Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance.

Authors:  M O Goodarzi; X Guo; J Cui; M R Jones; T Haritunians; A H Xiang; Y-D I Chen; K D Taylor; T A Buchanan; W A Hsueh; L J Raffel; J I Rotter
Journal:  Diabetologia       Date:  2013-03-14       Impact factor: 10.122

6.  Dissection of hepatic versus extra-hepatic insulin clearance: Ethnic differences in childhood.

Authors:  Francesca Piccinini; David C Polidori; Barbara A Gower; Jose R Fernandez; Richard N Bergman
Journal:  Diabetes Obes Metab       Date:  2018-08-20       Impact factor: 6.577

Review 7.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

8.  Insulin sensitivity and insulin clearance are heritable and have strong genetic correlation in Mexican Americans.

Authors:  Mark O Goodarzi; Carl D Langefeld; Anny H Xiang; Yii-Der I Chen; Xiuqing Guo; Anthony J G Hanley; Leslie J Raffel; Fouad Kandeel; Jerry L Nadler; Thomas A Buchanan; Jill M Norris; Tasha E Fingerlin; Carlos Lorenzo; Marian J Rewers; Steven M Haffner; Donald W Bowden; Stephen S Rich; Richard N Bergman; Jerome I Rotter; Richard M Watanabe; Lynne E Wagenknecht
Journal:  Obesity (Silver Spring)       Date:  2014-04       Impact factor: 5.002

Review 9.  Pivotal role of microRNA-33 in metabolic syndrome: A systematic review.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi
Journal:  ARYA Atheroscler       Date:  2013-11

10.  The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management.

Authors:  Mihai Dumitru Porojan; Andreea Cătană; Radu A Popp; Dan L Dumitrascu; Cornelia Bala
Journal:  Ther Clin Risk Manag       Date:  2015-11-27       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.